{"id":23091,"date":"2023-09-07T06:42:01","date_gmt":"2023-09-07T10:42:01","guid":{"rendered":"https:\/\/platohealth.ai\/goldwater-institute-weighs-in-against-fda-on-cell-surgical-network-lawsuit-appeal-the-niche\/"},"modified":"2023-09-07T12:19:31","modified_gmt":"2023-09-07T16:19:31","slug":"goldwater-institute-weighs-in-against-fda-on-cell-surgical-network-lawsuit-appeal-the-niche","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/goldwater-institute-weighs-in-against-fda-on-cell-surgical-network-lawsuit-appeal-the-niche\/","title":{"rendered":"Goldwater Institute weighs in against FDA on Cell Surgical Network lawsuit appeal – The Niche","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
An important appeals case is pending not just for the defendants Cell Surgical Network, et al., but also for the FDA. It could impact the stem cell field very broadly too.<\/p>\n
Hopefully, we\u2019ll get a decision before the end of this year.<\/p>\n
Cell Surgical Network is a large chain of unproven stem cell clinics. Drs. Elliot Lander and Mark Berman founded the network.<\/p>\n
The clinics in the network market adipose cell preparations for a variety of medical conditions. None of these applications have FDA approval. The agency filed suit seeking an injunction with the case ending up in California federal district court. The FDA lost and now their appeal is pending at the Ninth Circuit.<\/p>\n
What\u2019s at the heart of the case? What\u2019s new?<\/p>\n